Page last updated: 2024-08-26

fibrinogen and Forestier-Certonciny Syndrome

fibrinogen has been researched along with Forestier-Certonciny Syndrome in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's2 (28.57)18.2507
2000's2 (28.57)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Al-Mudhaffer, S; Donnelly, S; Kenny, D; MacMullan, PA; Madigan, A; McCarthy, CJ; McCarthy, EM; McCarthy, GM; Molloy, ES2
Malone, CB; McCarthy, GM1
Buyse, M; Schreiber, S1
Kikuchi, M; Mihara, N; Shiigai, T; Shintani, S; Tamaki, M; Tsuruoka, S1
Matsui, Y; Shiigai, T; Shintani, S1
Kashiwazaki, S; Osada, H; Tadenuma, T; Takahashi, T1

Other Studies

7 other study(ies) available for fibrinogen and Forestier-Certonciny Syndrome

ArticleYear
Plasma fibrinogen along with patient-reported outcome measures enhances management of polymyalgia rheumatica: a prospective study.
    The Journal of rheumatology, 2014, Volume: 41, Issue:5

    Topics: Adrenal Cortex Hormones; Aged; Aged, 80 and over; Biomarkers; Blood Sedimentation; C-Reactive Protein; Drug Monitoring; Female; Fibrinogen; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Polymyalgia Rheumatica; Prospective Studies; ROC Curve; Severity of Illness Index; Visual Analog Scale

2014
Plasma fibrinogen is an accurate marker of disease activity in patients with polymyalgia rheumatica.
    Rheumatology (Oxford, England), 2013, Volume: 52, Issue:3

    Topics: Aged; Aged, 80 and over; Biomarkers; Blood Sedimentation; C-Reactive Protein; Disease Progression; Female; Fibrinogen; Humans; Male; Middle Aged; Polymyalgia Rheumatica; Predictive Value of Tests; Prospective Studies; ROC Curve

2013
Polymyalgia rheumatica as an unusual cause of pleural and pericardial effusion.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2005, Volume: 11, Issue:1

    Topics: Aged; Blood Sedimentation; Female; Fibrinogen; Glucocorticoids; Humans; Pericardial Effusion; Pleural Effusion; Polymyalgia Rheumatica; Prednisolone

2005
The CRP initial response to treatment as prognostic factor in patients with polymyalgia rheumatica.
    Clinical rheumatology, 1995, Volume: 14, Issue:3

    Topics: Aged; Blood Sedimentation; C-Reactive Protein; Female; Fibrinogen; Humans; Male; Middle Aged; Polymyalgia Rheumatica; Prednisolone; Prognosis; Prospective Studies

1995
Immunofluorescence study of immune complexes in polymyalgia rheumatica.
    Journal of the neurological sciences, 1995, Volume: 128, Issue:1

    Topics: Angiography; Antigen-Antibody Complex; C-Reactive Protein; Fibrinogen; Fluorescent Antibody Technique; Giant Cell Arteritis; Humans; Immunoglobulin A; Immunoglobulin G; Immunohistochemistry; Male; Middle Aged; Muscles; Polymyalgia Rheumatica

1995
Polymyalgia rheumatica (PMR): clinical, laboratory, and immunofluorescence studies in 13 patients.
    Clinical neurology and neurosurgery, 2002, Volume: 104, Issue:1

    Topics: Aged; Aged, 80 and over; Disease Progression; Female; Fibrinogen; Fluorescent Antibody Technique; Humans; Immunoglobulin A; Immunoglobulin G; Inflammation; Male; Middle Aged; Muscle, Skeletal; Polymyalgia Rheumatica; Retrospective Studies

2002
[Case of polymyalgia rheumatica].
    Nihon rinsho. Japanese journal of clinical medicine, 1974, May-10, Volume: 32, Issue:5

    Topics: Aged; Alpha-Globulins; Blood Sedimentation; Female; Fibrinogen; Humans; Polymyalgia Rheumatica

1974